Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Qihan Starts Trial of Gene-Edited iPSC-Derived NK Cell Therapy for Leukemia

publication date: Jul 20, 2023

Hangzhou Qihan Biotech has been approved to start China trials of QN-019a for CD19-positive relapsed/refractory aggressive B-cell non-Hodgkin lymphoma, the first IND approved in China for a gene-edited iPSC-derived cell therapy. Qihan uses multiplexable genome editing technology to modify human Induced Pluripotent Stem Cells (iPSCs) and differentiate them into a natural killer (NK) cell therapy product that targets CD19-positive B-cell lymphoma. Qihan uses its multiplexable genome editing technologies to create cell therapies and advance organ transplantation. Its goal is to deliver off-the-shelf cell therapies with long-term efficacy. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here